A Study in Which Non-metastatic Castration-resistant Prostate Cancer (nmCRPC) Patients for Whom a Decision to Treat With Darolutamide Has Been Made Before Enrollment Are Observed and Certain Outcomes Are Described
Public ClinicalTrials.gov record NCT04122976. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Darolutamide Observational Study in Non-metastatic Castration-resistant Prostate Cancer Patients
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to find out in the real-world setting, if darolutamide is safe and effective for patients diagnosed with prostate cancer that has not spread to other parts of the body. When a patient is enrolled to the study, his/her physician would have already made the decision to treat patient with darolutamide per local standard practice.
Study identification
- NCT ID
- NCT04122976
- Recruitment status
- Active, not recruiting
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 805 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 30, 2020 (Actual)
- Primary completion
- Jul 20, 2026 (Actual)
- Completion
- Oct 7, 2026 (Estimated)
- Last update posted
- Aug 6, 2026
2020 – 2026
United States locations
- U.S. sites
- 24
- U.S. states
- 16
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Urology Centers of Alabama | Homewood | Alabama | 35209 | — |
| Arizona Institute of Urology | Tucson | Arizona | 85704 | — |
| Genesis Comprehensive Prostate Cancer Center | San Diego | California | 92123 | — |
| The Urology Center of Colorado | Denver | Colorado | 80211 | — |
| New Jersey Urology | Englewood | Colorado | 07631 | — |
| Manatee Medical Research Institute | Bradenton | Florida | 34205 | — |
| Advanced Urology Institute | Daytona Beach | Florida | 32114 | — |
| Research by Design, LLC | Chicago | Illinois | 60643 | — |
| First Urology, PSC | Jeffersonville | Indiana | 47130 | — |
| Wichita Urology Group | Wichita | Kansas | 67206 | — |
| Southcoast Centers for Cancer Care | Fairhaven | Massachusetts | 02719 | — |
| Oregon Urology Institute | Springfield | Massachusetts | 01106 | — |
| Beacon Cancer Care | Beacon | New York | 83814 | — |
| Integrated Medical Professionals, PLLC | North New Hyde Park | New York | 11042 | — |
| Premier Medical Group of the Hudson Valley, PC | Poughkeepsie | New York | 12603 | — |
| Associated Medical Professional Urology | Syracuse | New York | 13210 | — |
| Associated Urologists of NC | Raleigh | North Carolina | 27612 | — |
| Keystone Urology Specialists | Lancaster | Pennsylvania | 17601 | — |
| Vanderbilt University Medical Center | Nashville | Tennessee | 37203 | — |
| Urology San Antonio | San Antonio | Texas | 78229 | — |
| Baylor Scott & White Medical Center - Temple | Temple | Texas | 76508 | — |
| Urology of Virginia | Virginia Beach | Virginia | 23462 | — |
| University of Washington | Seattle | Washington | 98101 | — |
| MultiCare Institute for Research & Innovation | Tacoma | Washington | 98405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 16 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04122976, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 6, 2026 · Synced Nov 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04122976 live on ClinicalTrials.gov.